Amgen
Patents, Design & Utilities
Last updated:
List of all Amgen patents 684 in total
| Status | Patent |
|---|---|
Application | Utility: NUCLEIC ACID BIOMARKER AND USE THEREOF Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Grant | Utility: Inhibitors of KRAS G12C and methods of using the same Filling date: 6 Sep 2025 Issue date: 5 May 2020 |
Grant | Design: Handheld drug delivery device Filling date: 6 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: Centralized authenticating abstraction layer with adaptive assembly line pathways Filling date: 6 Sep 2025 Issue date: 5 May 2020 |
Application | Utility: ANTIBODIES TO OPGL Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: CONTROL OF TOTAL AFUCOSYLATED GLYCOFORMS OF ANTIBODIES PRODUCED IN CELL CULTURE Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Grant | Utility: Compounds that inhibit Mcl-1 protein Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Methods of reducing or eliminating protein modification and degradation arising from exposure to UV light Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Design: Autoinjector with removable autoinjector cap Filling date: 6 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Rotationally biased insertion mechanism for a drug delivery pump Filling date: 6 Sep 2025 Issue date: 21 Apr 2020 |
Application | Utility: METHODS FOR TREATING BONE GAP DEFECTS Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: CHIMERIC RECEPTORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: DRUG DELIVERY DEVICE HAVING DAMPING MECHANISM Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: PROTEIN BIOMARKER AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: COMBINATION THERAPY OF CARDIAC MYOSIN ACTIVATOR AND SINUS NODE IF CURRENT INHIBITOR Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Grant | Utility: Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoin- doline-1, 3-dione Filling date: 6 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: Crystalline antibody formulations Filling date: 6 Sep 2025 Issue date: 7 Apr 2020 |
Application | Utility: INJECTION SYSTEMS FOR DRUG DELIVERY WITH INTERNAL FORCE TRANSMISSION Filling date: 6 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: ANTIBODIES BINDING TO SOLUBLE BCMA Filling date: 6 Sep 2025 Issue date: 2 Apr 2020 |
Grant | Utility: Chimeric receptors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 24 Mar 2020 |
Application | Utility: METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS Filling date: 6 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: ANTI-TNF ALPHA ANTIBODY FORMULATIONS Filling date: 6 Sep 2025 Issue date: 19 Mar 2020 |
Grant | Design: Autoinjector with removable cap Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Design: On-body injector for drug delivery Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Design: On-body injector Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: FEED MEDIA Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Grant | Design: On-body injector for drug delivery Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Design: On-body injector for drug delivery Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Drug delivery device with vacuum assisted securement and/or feedback Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Process control systems and methods for use with filters and filtration processes Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: DECREASING ORNITHINE METABOLISM TO DECREASE THE HIGH MANNOSE GLYCOFORM CONTENT OF RECOMBINANT PROTEINS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: PEGYLATED CARFILZOMIB COMPOUNDS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: KRAS G12C INHIBITORS AND METHODS OF USING THE SAME Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Antigen Binding Proteins Capable of Binding Thymic Stromal Lymphopoietin Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Heterodimeric Bispecific Antibodies Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Capture purification processes for proteins expressed in a non-mammalian system Filling date: 6 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: COMPOUNDS THAT INHIBIT MCL-1 PROTEIN Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Human antigen binding proteins that bind .beta.-Klotho, FGF receptors and complexes thereof Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Device and method for making aseptic connections Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: KRAS G12C INHIBITORS AND METHODS OF USING THE SAME Filling date: 6 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: Antibody Constructs for CLDN18.2 and CD3 Filling date: 6 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: Interleukin-2 muteins for the expansion of T-regulatory cells Filling date: 6 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Methods for isolating antibodies that bind sclerostin Filling date: 6 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: Binding Agents Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: HETEROCYCLIC COMPOUNDS AND THEIR USES Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Showing 550 to 600 of 684 patents.